Efficacy and safety of the SGLT2 inhibitor dapagliflozin in type 1 diabetes: A meta-analysis of randomized controlled trials

Sodium glucose cotransporter-2 (SGLT2) is a sodium-dependent glucose transporter responsible for renal absorption of glucose. Dapagliflozin is an SGLT2 inhibitor used in patients with type 1 diabetes to promote urinary glucose excretion, but to date, randomized controlled trials (RCTs) to evaluate t...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Yuxin, Jiang, Zeju, Wei, Yiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918543/
https://www.ncbi.nlm.nih.gov/pubmed/33680104
http://dx.doi.org/10.3892/etm.2021.9813

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918543/
https://www.ncbi.nlm.nih.gov/pubmed/33680104
http://dx.doi.org/10.3892/etm.2021.9813

Ejemplares similares